BCM
GNMK

BCK Capital Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

BCK Capital Management’s Portfolio GNMK Stock Details GNMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-55,250
Closed -$1.32M – 160
2021
Q1 		$1.32M Buy
+55,250
New +$1.03M 0.73% 31

BCK Capital Management's GNMK Position: Q2 2021 in Review

BCK Capital Management sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 55,250 shares — an estimated $1.32M sold.

BCK Capital Management first reported a position in GNMK in Q1 2021 and held it in 1 quarter. The position peaked at $1.32M in Q1 2021. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.

  • BCK Capital Management reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
  • BCK Capital Management sold 55,250 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $1.32M.
  • BCK Capital Management first reported a position in GenMark Diagnostics, Inc in Q1 2021 and held it in 1 quarter.
  • BCK Capital Management's GenMark Diagnostics, Inc position peaked at $1.32M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.

Based on BCK Capital Management's 13F filing for Q2 2021, filed 20 Jul 2021.